Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 293,000 | 271,000 | 276,000 | 253,000 | 241,000 |
| Cost of Goods | 39,000 | 46,000 | 50,000 | 39,000 | 44,000 |
| Gross Profit | 254,000 | 225,000 | 226,000 | 214,000 | 197,000 |
| Operating Expenses | 347,000 | 408,000 | 165,000 | 157,000 | 455,000 |
| Operating Income | -91,000 | -183,000 | 61,000 | 57,000 | -258,000 |
| Interest Expense | 5,000 | 10,000 | 10,000 | 10,000 | 8,000 |
| Other Income | 8,000 | 12,000 | 11,000 | 11,000 | 11,000 |
| Pre-tax Income | -88,000 | -181,000 | 62,000 | 58,000 | -255,000 |
| Income Tax | -11,000 | -46,000 | 23,000 | 14,000 | -72,000 |
| Net Income Continuous | -77,000 | -135,000 | 39,000 | 44,000 | -183,000 |
| Net Income | $-77,000 | $-135,000 | $39,000 | $44,000 | $-183,000 |
| EPS Basic Total Ops | -0.56 | -0.98 | 0.28 | 0.32 | -1.30 |
| EPS Basic Continuous Ops | -0.57 | -0.98 | 0.28 | 0.32 | -1.31 |
| EPS Diluted Total Ops | -0.54 | -0.98 | 0.27 | 0.31 | -1.27 |
| EPS Diluted Continuous Ops | -0.55 | -0.98 | 0.27 | 0.31 | -1.27 |
| EBITDA(a) | $-97,000 | $-176,000 | $67,000 | $63,000 | $-254,000 |